Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1978 August; 62(2): 294–301.
PMCID: PMC371766

Human erythrocyte hexokinase deficiency. Characterization of a mutant enzyme with abnormal regulatory properties.


In the erythrocytes of a patient with hereditary nonspherocytic hemolytic anemia, a homozygous expression of hexokinase deficiency was detected. The mutant enzyme was characterized by normal kinetic parameters with respect to its substrates, glucose and MgATP2-, normal pH optimum, normal heat stability at 40 degrees C, but abnormal behavior with respect to its regulation by glucose-1,6-diphosphate and inorganic phosphate, and an altered electrophoretic pattern. Interpretation of the results revealed the presence of two different hexokinases type I in normal human erythrocytes: one enzyme with a high affinity for glucose-1,6-diphosphate, the inhibition of which is regulated by inorganic phosphate; and another enzyme with a lower affinity for the inhibitor, not regulated by inorganic phosphate. The former enzyme was not detectable in the erythrocytes of the patient, whereas the presence of the latter enzyme could be demonstrated.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Löhr GW, Waller HD, Anschütz F, Knopp A. Hexokinasemangel in Blutzellen bei einer Sippe mit familiärer Panmyelopathie (Typ Fanconi) Klin Wochenschr. 1965 Aug 15;43(16):870–875. [PubMed]
  • Valentine WN, Oski FA, Paglia DE, Baughan MA, Schneider AS, Naiman JL. Hereditary hemolytic anemia with hexokinase deficiency. Role of hexokinase in erythrocyte aging. N Engl J Med. 1967 Jan 5;276(1):1–11. [PubMed]
  • Malone JI, Winegrad AI, Oski FA, Holmes EW., Jr Erythrocyte hexokinase isoenzyme patterns in hereditary hemoglobinopathies. N Engl J Med. 1968 Nov 14;279(20):1071–1077. [PubMed]
  • Necheles TF, Rai US, Cameron D. Congenital nonspherocytic hemolytic anemia associated with an unusual erythrocyte hexokinase abnormality. J Lab Clin Med. 1970 Oct;76(4):593–602. [PubMed]
  • Keitt AS. Hemolytic anemia with impaired hexokinase activity. J Clin Invest. 1969 Nov;48(11):1997–2007. [PMC free article] [PubMed]
  • Moser K, Ciresa M, Schwarzmeier J. Hexokinasemangel bei hämolytischer Anämie. Med Welt. 1970 Nov 14;46:1977–1981. [PubMed]
  • Goebel KM, Gassel WD, Goebel FD, Kaffarnik H. Hemolytic anemia and hexokinase deficiency associated with malformations. Klin Wochenschr. 1972 Sep 1;50(17):849–851. [PubMed]
  • Rijksen G, Schoop I, Staal GE. Properties of human erythrocyte hexokinase related to cell age. Clin Chim Acta. 1977 Oct 1;80(1):193–202. [PubMed]
  • Rijksen G, Staal GE. Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta. 1977 Nov 23;485(1):75–86. [PubMed]
  • Rijksen G, Staal GE. Regulation of human erythrocyte hexokinase by glucose-1, 6-diphosphate and inorganic phosphate. FEBS Lett. 1977 Aug 1;80(1):61–65. [PubMed]
  • Staal GE, Akkerman JW, Eggermont E, van Biervliet JP. A new variant of glucosephosphate isomerase deficiency: GPI-Kortrijk. Clin Chim Acta. 1977 Jul 1;78(1):121–127. [PubMed]
  • Minakami S, Suzuki C, Saito T, Yoshikawa H. Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes. J Biochem. 1965 Dec;58(6):543–550. [PubMed]
  • Nakato M, Nakayama T, Kankura T. A new method for separation of human blood components. Nat New Biol. 1973 Nov 21;246(151):94–94. [PubMed]
  • Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976 Aug;88(2):328–333. [PubMed]
  • Rijksen G, Staal GE. Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta. 1976 Sep 14;445(2):330–341. [PubMed]
  • Gerber G, Preissler H, Heinrich R, Rapoport SM. Hexokinase of human erythrocytes. Purification, kinetic model and its application to the conditions in the cell. Eur J Biochem. 1974 Jun 1;45(1):39–52. [PubMed]
  • Kosow DP, Oski FA, Warms JV, Rose IA. Regulation of mammalian hexokinase: regulatory differences between isoenzyme I and II. Arch Biochem Biophys. 1973 Jul;157(1):114–124. [PubMed]
  • Rose IA, Warms JV, Kosow DP. Specificity for the glucose-6-P inhibition site of hexokinase. Arch Biochem Biophys. 1974 Oct;164(2):729–735. [PubMed]
  • Kaplan JC, Beutler E. Hexokinase isoenzymes in human erythrocytes. Science. 1968 Jan 12;159(3811):215–216. [PubMed]
  • Rogers PA, Fisher RA, Harris H. An examination of the age-related patterns of decay of the hexokinases of human red cells. Clin Chim Acta. 1975 Dec 15;65(3):291–298. [PubMed]
  • Buc HA, Leroux JP, Garreau H, Marchand JC, Cartier P. Metabolic regulation in enzyme-deficient red cells. Enzyme. 1974;18(1):19–36. [PubMed]
  • Katzen HM, Schimke RT. Multiple forms of hexokinase in the rat: tissue distribution, age dependency, and properties. Proc Natl Acad Sci U S A. 1965 Oct;54(4):1218–1225. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation